09/10/2026
Redsenol® | Rare Ginsenoside Clinical Research🔬
Health Canada has completed its review of the Redsenol-1 Plus Clinical Trial Amendment and indicated no objection to the proposed study.👏👏
Research continues on rare ginsenosides and cancer-related fatigue.👍👍
NCT05664009